Treatment update for allergic rhinitis.
This manuscript addresses the pathogenesis of allergic rhinitis, use of nasal provocation as a method to assess inflammatory mediators and the role of cytokines, and topical glucocorticosteroids. Immunologic changes of allergen immunotherapy, pharmacotherapy with a focus on non-sedating, and topical antihistamines are discussed. The antiinflammatory potential of fexofenadine, azelastine, and newer therapeutic modalities with anti-IgE are addressed.
Frieri
M
M
Department of Medicine and Pediatrics, Nassau University Medical Center, and State University of New York at Stony Brook, Stony Brook, New York, USA.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists